Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 8Active not recruiting 6Completed 4Withdrawn 2Terminated 2Suspended 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Other hematologic neoplasm 1Myeloid 1

Conditions

Thrombocythemia, Essential 1Primary Myelofibrosis 1Polycythemia Vera 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1

Interventions

Specimen Handling 3venetoclax 2Biopsy 2vactosertib 1regorafenib 1iadademstat 1fludarabine phosphate 1fludarabine 1decitabine and cedazuridine drug combination 1ammonium trichloro(dioxoethylene-O,O'-)tellurate 1aldesleukin 1X-Rays 1TAK-243 1Photons 1Melphalan 1KB004 1Interleukin-2 1IL32 protein, human 1Genetic Testing 1Cyclophosphamide 1CYC065 1CA-4948 1Azacitidine 1Ascorbic Acid 1Actinium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × decitabine and cedazuridine drug combination × Myeloid × Clear all
NCT06661915 2026-05-29

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

National Cancer Institute (NCI)

Phase 2 Suspended
62 enrolled
Myeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Myelodysplastic-Myeloproliferative Diseases, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡